Period of time： 2006年7期
Publisher： Springer Publishing Company
Founded in： 1978
Total resources： 46
ISSN： 0344-5704
Subject： R73 Oncology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Cancer Chemotherapy and Pharmacology,volume 58,issue 7
Menu
By Ariyoshi Yutaka,Mitsudomi Tetsuya,Ogawa Makoto,Saito Hidehiko,Shimokata Kaoru,Ueda Ryuzo in (2006)
Cancer Chemotherapy and Pharmacology,volume 58,issue 7 , Vol. 58, Iss. 7, 2006-11 , pp.
Access to resources
Recommend
Impact of
By Johnson Bruce,Jackman David,Jänne Pasi in (2006)
Cancer Chemotherapy and Pharmacology,volume 58,issue 7 , Vol. 58, Iss. 7, 2006-11 , pp.Defining clinically relevant molecular subsets of lung cancer
Cancer Chemotherapy and Pharmacology,volume 58,issue 7 , Vol. 58, Iss. 7, 2006-11 , pp.The impact and role of
By Toyooka Shinichi,Soh Junichi,Shigematsu Hisayuki,Aoe Motoi,Date Hiroshi in (2006)
Cancer Chemotherapy and Pharmacology,volume 58,issue 7 , Vol. 58, Iss. 7, 2006-11 , pp.Clinical development of EGFR-tyrosine kinase inhibitors in Japan
By Nakagawa Kazuhiko in (2006)
Cancer Chemotherapy and Pharmacology,volume 58,issue 7 , Vol. 58, Iss. 7, 2006-11 , pp.By Nishio Kazuto,Arao Tokuzo,Kato Terufumi,Yokote Hideyuki in (2006)
Cancer Chemotherapy and Pharmacology,volume 58,issue 7 , Vol. 58, Iss. 7, 2006-11 , pp.Development of NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor
By Kimura Shinya,Niwa Tomoko,Hirabayashi Kazuko,Maekawa Taira in (2006)
Cancer Chemotherapy and Pharmacology,volume 58,issue 7 , Vol. 58, Iss. 7, 2006-11 , pp.
Previous
Next